The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease-Reference-Cited by-同舟云学术

The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease

Published:2016-07 Issue:4 Volume:36 Page:319-330
ISSN:0270-9295
Container-title:Seminars in Nephrology
language:en
Short-container-title:Seminars in Nephrology

Author:

Wang Virginia,Vilme Helene,Maciejewski Matthew L.,Boulware L. Ebony

Publisher

Elsevier BV

Subject

Nephrology

Reference37 articles.

1. Cost-effectiveness in health and medicine;Gold,1996

2. The challenge of understanding health care costs and charges;Arora;AMA J Ethics,2015

3. Medical costs of CKD in the Medicare population;Honeycutt;J Am Soc Nephrol,2013

4. Cost implications of caring for chronic kidney disease: are interventions cost-effective?;Trivedi;Adv Chronic Kidney Dis,2010

5. US Renal Data System. USRDS 2014 annual data report: atlas of chronic kidney disease and end stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2014.

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Service Utilization Patterns and Direct Medical Costs of Hospitalization in Patients With Renal Failure Before and After Initiating Home Peritoneal Dialysis;Value in Health Regional Issues;2024-05

2. BTF3L4 enhances malignant phenotypes through modulating tumor cell function and immune microenvironment in glioma;The American Journal of Pathology;2024-02

3. The Awareness, Prevalence, and Risk Factors of Chronic Kidney Disease Among Diabetes Mellitus and Hypertensive Patients in the Aseer Region, Saudi Arabia;Cureus;2024-02-01

4. Willingness to pay for haemodialysis among patients with chronic kidney disease in Abuja, Nigeria;BMC Nephrology;2024-01-23

5. Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan;Advances in Therapy;2024-01-19